BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 24303881)

  • 21. Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.
    Fernández de Larrea C; Martínez-Pozo A; Mercadal S; García A; Gutierrez-García G; Valera A; Ghita G; Colomo L; Gainza E; Villamor N; Nomdedeu B; Estrach T; Montserrat E; Campo E; López-Guillermo A
    Br J Haematol; 2011 May; 153(3):334-40. PubMed ID: 21375524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
    Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
    Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database.
    Solal-Céligny P; Bellei M; Marcheselli L; Pesce EA; Pileri S; McLaughlin P; Luminari S; Pro B; Montoto S; Ferreri AJ; Deconinck E; Milpied N; Gordon LI; Federico M
    J Clin Oncol; 2012 Nov; 30(31):3848-53. PubMed ID: 23008294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma.
    Schwartzberg L; Hermann R; Flinn I; Flora D; Hsi ED; Hamid O; Shi P; Lin BK; Myrand SP; Nguyen TS; Dreyling M
    Br J Haematol; 2014 Jul; 166(1):91-7. PubMed ID: 24673609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
    Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
    Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma.
    Krishnadasan R; Bifulco C; Kim J; Rodov S; Zieske AW; Vanasse GJ
    Br J Haematol; 2006 Oct; 135(1):72-5. PubMed ID: 16939500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low grade follicular lymphoma with high proliferation index; diagnostic and management issues.
    Das S; Basu D; Dubashi B; Jain A
    Indian J Pathol Microbiol; 2012; 55(4):516-8. PubMed ID: 23455792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary gastrointestinal follicular lymphoma: single-center 12-year experiences.
    Na YJ; Kim ER; Kim SJ; Kim WS; Ko YH; Son HJ
    Hepatogastroenterology; 2012 May; 59(115):751-3. PubMed ID: 22020908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.
    Wahlin BE; Aggarwal M; Montes-Moreno S; Gonzalez LF; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
    Clin Cancer Res; 2010 Jan; 16(2):637-50. PubMed ID: 20068089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.
    Mondello P; Fama A; Larson MC; Feldman AL; Villasboas JC; Yang ZZ; Galkin I; Svelolkin V; Postovalova E; Bagaev A; Ovcharov P; Varlamova A; Huet S; Tesson B; McGrath KR; Slager S; Link BK; Syrbu S; Novak AJ; Habermann TM; Witzig TE; Nowakowski GS; Salles G; Cerhan JR; Ansell SM
    Blood Cancer J; 2021 Jul; 11(7):130. PubMed ID: 34267181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrafollicular PD1 and Intrafollicular CD3 Expression Are Associated With Survival in Follicular Lymphoma.
    Meirav K; Ginette S; Tamar T; Iris B; Arnon N; Abraham A
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):645-649. PubMed ID: 28733197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
    Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
    Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas.
    Samols MA; Smith NE; Gerber JM; Vuica-Ross M; Gocke CD; Burns KH; Borowitz MJ; Cornish TC; Duffield AS
    Am J Clin Pathol; 2013 Oct; 140(4):579-87. PubMed ID: 24045557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
    Czuczman MS; Weaver R; Alkuzweny B; Berlfein J; Grillo-López AJ
    J Clin Oncol; 2004 Dec; 22(23):4711-6. PubMed ID: 15483015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine-related genes play critical roles in extrafollicular growth of follicular lymphoma cells.
    Yoshida N; Miyoshi H; Arakawa F; Nakashima K; Kawamoto K; Seto M; Ohshima K
    Hematol Oncol; 2020 Dec; 38(5):673-679. PubMed ID: 32835439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
    Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
    Richendollar BG; Pohlman B; Elson P; Hsi ED
    Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.
    Guadagnolo BA; Li S; Neuberg D; Ng A; Hua L; Silver B; Stevenson MA; Mauch P
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):928-34. PubMed ID: 16243446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
    Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
    Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.